Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Helicobacter Pylori Treatment Between Modified Quadruple Therapy and Tailored Eradication Based on the Presence of Clarithromycin Resistance

NCT05002595 is registered in ClinicalTrials.gov with Soonchunhyang University Hospital as lead sponsor.

NCT NCT05002595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05002595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Helicobacter Pylori Treatment Between Modified Quadruple Therapy and Tailored Eradication Based on the Presence of Clarithromycin Resistance
Lead sponsor
Soonchunhyang University Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
December 31, 2021
Enrollment
270 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

h. pylori infection